| 2015 | D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale | THROMBOSIS AND HAEMOSTASIS |
| 2021 | D-dimer predicts poor hospitalisation outcomes in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2022 | DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
| DIABETES & METABOLISM JOURNAL |
| 2022 | Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
| ANNALS OF ONCOLOGY |
| 2018 | Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
| GUT AND LIVER |
| 2017 | Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2020 | Dact2 is involved in the regulation of epithelial-mesenchymal transition | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2017 | Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial
| INTERNATIONAL JOURNAL OF CANCER |
| 2021 | Danshen Extracts Prevents Obesity and Activates Mitochondrial Function in Brown Adipose Tissue
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
| BMC MEDICINE |
| 2021 | Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study
| JOURNAL OF HEMATOLOGY & ONCOLOGY |
| 2023 | Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
| ANNALS OF HEMATOLOGY |
| 2016 | Daratumumab 투여를 받은 다발성 골수종 환자에서 비예기항체 동정검사상 범응집 소견을 보인 1예
| Korean Journal of Blood Transfusion (대한수혈학회지) |
| 2020 | Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
| BLOOD CANCER JOURNAL |
| 2021 | Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEW ENGLAND JOURNAL OF MEDICINE |
| 2016 | Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service
| DIABETES & METABOLISM JOURNAL |
| 2022 | Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2020 | Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database
| DIABETES & METABOLISM JOURNAL |
| 2022 | Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01 | ANNALS OF ONCOLOGY |
| 2021 | Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
| JOURNAL OF KOREAN MEDICAL SCIENCE |
